People: GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

3,183.40INR
30 Apr 2015
Change (% chg)

-- (--)
Prev Close
Rs3,183.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
14,898
52-wk High
Rs3,550.00
52-wk Low
Rs2,365.00

Search Stocks

Summary

Name Age Since Current Position

Deepak Parekh

70 Non-Executive Chairman of the Board

Venkatraman Thyagarajan

68 Non-Executive Vice Chairman of the Board

Andrew Aristidou

2014 Chief Financial Officer, Executive Director

H. Buch

2012 Executive Vice President - Pharmaceuticals

Ajay Nadkarni

2011 Compliance Officer, Company Secretary, General Manager - Administration

S. Khanna

Vice President - Finance

R. Bartaria

2009 Vice President - Pharmaceuticals

S. Dheri

2012 Vice President - Biologicals

K. Hazari

2011 Vice President - Legal & Corporate Affairs

C. Renganathan

2009 Vice President - Pharmaceuticals

Hasit Joshipura

2006 Managing Director, Executive Director

V. Desai

2013 General Manager - Medical & Clinical Research

Ronald Sequeira

2007 Executive Director - Human Resources, Director

Raju Krishnaswamy

2011 Executive Director - Technical, Director

Simon Harford

2010 Non-Executive Director

R. Bajaaj

2002 Non-Executive Independent Director

Anjali Bansal

2013 Non-Executive Independent Director

Pradeep Bhide

2010 Non-Executive Independent Director

Nihal Kaviratne

71 2005 Non-Executive Independent Director

P. Nayak

70 2003 Non-Executive Independent Director

Anami Roy

61 2011 Non-Executive Independent Director

D. Sundaram

60 2009 Non-Executive Independent Director

Biographies

Name Description

Deepak Parekh

Mr. Deepak S. Parekh is Non-Executive Chairman of the Board of GlaxoSmithKline Pharmaceuticals Ltd. He is a Chairman of Investors / Shareholders Grievance Committee, Member of Audit Committee.

Venkatraman Thyagarajan

Mr. V. Thyagarajan is Non-Executive Vice Chairman of the Board of GlaxoSmithKline Pharmaceuticals Ltd. He is a Member of Audit Committee.

Andrew Aristidou

H. Buch

Mr. H. Buch is an Executive Vice President - Pharmaceuticals of GlaxoSmithKline Pharmaceuticals Ltd.

Ajay Nadkarni

Mr. Ajay A. Nadkarni is Compliance Officer, Company Secretary, General Manager - Administration of GlaxoSmithKline Pharmaceuticals Ltd.

S. Khanna

Mr. S. Khanna is Vice President - Finance of GlaxoSmithKline Pharmaceuticals Ltd.

R. Bartaria

Mr. R. Bartaria is Vice President - Pharmaceuticals of GlaxoSmithKline Pharmaceuticals Ltd.

S. Dheri

Mr. S. Dheri is Vice President - Biologicals of Glaxosmithkline Pharmaceutical Ltd., since April 1, 2012.

K. Hazari

Mr. K. Hazari is Vice President - Legal & Corporate Affairs of GlaxoSmithKline Pharmaceuticals Ltd., since August 1, 2011.

C. Renganathan

Mr. C. T. Renganathan is Vice President - Pharmaceuticals of GlaxoSmithKline Pharmaceuticals Ltd.

Hasit Joshipura

Dr. Hasit B. Joshipura is Managing Director, Executive Director of Glaxosmithkline Pharmaceutical Limited. Dr. Joshipura is a graduate in Electrical Engineering from VJTI - Bombay University and a Post Graduate from the Indian Institute of Management - Ahmedabad. He has completed his Doctorate programme at the School of Management at lIT Mumbai. After having spent about three years with Tata Administrative Services, Dr. Joshipura spent 16 years with the Unilever Group of companies in India and held positions of increasing responsibility in commercial, sales, marketing and business management functions. He joined the pharmaceutical business of Johnson & Johnson Limited as President & Executive Director in October 2001. Dr. Joshipura was the Chair person for the Corporate Contributions Programme, as well as the lead for Government Affairs for the Johnson & Johnson group of businesses in India. In October 2006, Dr. Joshipura was appointed Vice President and General Manager designate India, Bangladesh and Sri Lanka and took over as Managing Director of the Company from lS January 2007. He is an Executive Committee Member of the Organisation of Pharmaceutical Producers of India (OPPI) and has been nominated by the Board of Governors of VJTI to their Senate. Dr. Joshipura is a Director of Biddle Sawyer Limited which forms a part of the GlaxoSmithKline Group Companies in India and is a member of the Investors/Shareholders Grievance Committee of the Company.

V. Desai

Ronald Sequeira

Mr. Ronald C. Sequeira is an Executive Director - Human Resources, Director of Glaxosmithkline Pharmaceutical Limited. Mr. Sequeira is an alumni of Loyola College, Chennai and XLRI, Jamshedpur and has 29 years of experience in the field on Human Resources with multinational companies in India. He began his HR career in 1984 as a Management Trainee with Union Carbide India Limited and gained employee relations experience in various positions. He was appointed Personnel Manager in 1990. In 1992, he moved to the HSBC Bank where he handled HR for East and West India and headed Resourcing and Development and later he was appointed HR Manager Asia Pacific, based in Hong Kong. Mr. Sequeira has also held the position of Head of Compensation and Employee Relations with HSBC, India. Mr. Sequeira joined Tata Power Company in 2004 as VP and Head of Human Resources with additional charge for the Company’s Corporate Social Responsibility function. He was also on the Tata Group’s HR steering Committee. He has been in the service of the Company since 2006 and was elevated to the Board in 2007. He is a Director of Biddle Sawyer Limited which forms part of the GlaxoSmithKline Group Companies in India. He is also a Director in Hill Properties Limited.

Raju Krishnaswamy

Mr. Raju Krishnaswamy is an Executive Director - Technical, Director of GlaxoSmithKline Pharmaceuticals Ltd., since March 16, 2011. Mr. Krishnaswamy has completed his B. Pharm from JSS college of Pharmacy Ooty and has undertaken Ex.MBA from ICFAI. Prior to joining the Company, Mr. Krishnaswamy worked as Senior Vice - President, Global Manufacturing with Wockhart Limited. In this capacity, he was the manufacturing operations of Wockhart in India, U.S.A and Ireland. He headed the contract manufacturing services and the R&D formulation for India and rest of the world countries. Earlier, Mr. Krishnaswamy has had stints with organisations like Cipla Limited, Bangalore and Ranbaxy Laboratories Limited. He was working on the Boards of Wockhart Infrastructure Development Limited and Wockhart Biopharm Limited.

Simon Harford

Mr. Simon Harford is Non-Executive Director of Glaxosmithkline Pharmaceutical Ltd. Mr. Harford is an MBA from the University of Virginia's Darden School. He joined GSK pic as Senior Vice-President Finance, Emerging Markets in June 2009. Prior to joining GSK, he was Group Vice-President and Corporate Controller for Avon Products in New York. Prior to that, Simon worked at Eli Lilly and Company as Vice-President and Corporate Controller in Indianapolis, having joined the company in 1988. Since that time, he took on finance roles of increasing responsibility in the United States and various European countries including Chief Financial Officer, Italy from 1998 - 2000, Head of Investor Relations from 2001 - 2004 and Chief Financial Officer, Europe, Middle East and Africa from 2004 - 2006.

R. Bajaaj

Mr. R. R. Bajaaj is Non-Executive Independent Director of Glaxosmithkline Pharmaceutical Limited. Mr. Bajaaj is a graduate in Science and Law. He joined Mahindra & Mahindra Limited as Management Trainee in 1964. He then moved on to Otis Elevator Company (India) Limited in their Field Operations Department in 1967 and held a series of senior roles within that Company including Head of Northern Regional Operations, Country Head for Middle East and South East Asia countries. Mr. Bajaaj returned to India as Managing Director of Otis Elevator Company (India) Limited in 1989. In 2000, he was appointed as Vice- President South and South East Asia operations based in Singapore. In 2001, he took up international assignment with an NGO Special Olympics Inc. as Managing Director, Asia Pacific. In 2006, he entered into a Joint Venture with the world’s Consulting Firm for Vertical Transportation, Lerch Bates which is Head quartered in Denver, U.S.

Anjali Bansal

Ms. Anjali P. Bansal is Non-Executive Independent Director of GlaxoSmithKline Pharmaceuticals Ltd. She received a master’s degree in International Affairs, with distinction, from Columbia University in New York, where she majored in International Finance and Business, as well as a bachelor’s degree in Computer Engineering from Gujarat University. Ms. A. Bansal is Managing Director of Spencer Stuart’s Indian business, which she was instrumental in establishing. Based in Mumbai, she also co-leads the firm’s Asia Pacific Board & CEO Succession practice. As an active member of the Global Board practice, she works in various geographies across the United States, Europe and Asia, advising Indian and multinational companies on CEO and senior executive search, Board governance and succession. She also consults with clients across sectors, including private equity, financial services, technology, industrial and consumer goods and services. In addition, she chairs the board of FWWB (Friends of Women’s World Banking), a development and livelihood-promoting institution, serves on the board of the United Way of Mumbai, and is a charter member of The Indus Entrepreneurs (TiE). Ms. A. Bansal is a frequent commentator on Board governance, CEO succession, entrepreneurship and other executive leadership issues. She is a regular columnist with publications such as Mint-The Wall Street Journal and The Economic Times: Corporate Dossier. Earlier, Ms. A. Bansal was with McKinsey & Company as a strategy consultant. Based in New York and Mumbai, she consulted with firms in financial services, private equity, industrial, and technology sectors.

Pradeep Bhide

Mr. Pradeep Vasudeo Bhide is Non-Executive Independent Director of Glaxosmithkline Pharmaceutical Ltd. He is Science and Law graduate from Delhi University, has done his Master’s in Business Administration from IGNOU. He is enrolled as an Advocate with Delhi Bar Council. Mr. Bhide joined the Indian Administrative Service in 1973 and has served for 37 years. He held a series of increasingly senior positions at the State and Central levels. He worked as Secretary for Department of Finance and then Department of Energy of Andhra Pradesh. He was a Deputy Secretary / Director in the Department of Economic Affairs, Ministry of Finance and served as Advisor to India’s Executive Director to the International Board for Reconstruction and Development, Washington. Mr. Bhide then served as Additional Secretary / Special Secretary in the Ministry of Home Affairs of the Government before being appointed as Secretary in the Department of Divestment with the Ministry of Finance. Mr. P. V. Bhide retired as Secretary, Department of Revenue, Ministry of Finance in January 2010, a position which he held from June 2007. He was appointed as Non-Executive Independent Director of the Company from 28th October 2010. He is a Director of Tube Investments India Limited, L&T Finance Limited, Ballarpur Industries Limited, NOCIL Limited, Heidelberg Cement India Limited, L&T Finance Holdings Limited and BILT Graphic Paper Products Limited. He is the Chairman of the Audit Committee of L&T Finance Limited and Ballarpur Industries Limited and the member of the Audit Committee of Heidelberg Cement India Limited and Tube Investments India Limited. He is also the member of the Investors / Shareholders Grievance Committee of Heidelberg Cement India Limited.

Nihal Kaviratne

Mr. Nihal Vijaya Devadas Kaviratne is Non-Executive Independent Director of Glaxosmithkline Pharmaceutical Limited. Mr. Nihal Kaviratne has an Honours degree in Economics from Mumbai University. He joined them in India as a Management Trainee in 1966, and held a series of senior roles including Head of Marketing Research and Economics and General Manager of Export Division. In 1984 he moved as Managing Director of the Detergents Division in Indonesia, and later became Regional Leader for Latin America and South Asia at Corporate Headquarters in London, Managing Director in Argentina and Chairman in Indonesia. He was appointed Senior Vice President - Development and Environmental Affairs, Unilever Asia, based in Singapore and Chairman of Unilever’s Home and Oral Care businesses in Asia. He was awarded the CBE for services to UK business interests and for sustainable development in Indonesia. He is a Director of Company since July 2005 and is the member of Audit Committee. Mr. Kaviratne is the Chairman of Akzo Nobel India Limited and of the Indian Cancer Society. He is President Commissioner of TVS Indonesia and a Director of several Singapore based companies including the DBS Group, SATS, StarHub and Wildlife Reserves Singapore.

P. Nayak

Mr. P. V. Nayak is Non-Executive Independent Director of Glaxosmithkline Pharmaceutical Limited. Mr. Nayak graduated with combined honours in Economics and Politics from the University of York, England. He then read law at Gray’s Inn, London. From 1970 to 1989, he held several senior level positions in Anil Starch Products, Borosil Glass Works (a corning subsidiary at that time) and Union Carbide. He also practiced management consultancy with A. F. Ferguson & Co. Mr. Nayak joined the Company in 1989 and was elevated to the Board in 1992. At the time of his retirement from service on 30th September 2003, he was Senior Executive Director in charge of Human Resources, Legal and Licensing, Corporate Communications, Administration and Agrivet Farm Care business. Earlier, he was also in charge of the Qualigens Fine Chemicals business. He was appointed as Non-Executive Director of the Company from 9th October 2003. At present, he holds 576 shares of the Company. Mr. Nayak is a Director of Siemens Limited, Virbac Animal Health India Private Limited and BNP Paribas Trustee India Private Limited. He is the Member of the Investor Grievance Committee and Remuneration Committee of Siemens Limited.

Anami Roy

Mr. Anami N. Roy is Non-Executive Independent Director of GlaxoSmithKline Pharmaceuticals Ltd., since November 4, 2011. He holds a Master degree in History and is a retired civil servant. During his 38 years long career in the Indian Police Service (“IPS”), he held with great distinction a range of assignments including some of the challenging and sensitive ones, both in the Maharashtra State and Government of India. He retired in May, 2010 as the Director General of Police (DGP), Maharashtra, heading a police force of 2,00,000. As the DGP Maharashtra, he was the advisor to the State Government for internal security, law and order and crime administration. Mr. Roy, as Police Commissioner of Mumbai for over three years has many instruments and schemes for making Police services more accessible to citizens and people-friendly. Citizen Facilitation Centers for providing time-bound, transparent, hassle-free solutions to people’s expectations from the Police were appreciated by people and media. As Managing Director of Police Housing Corporation, he galvanized the work of planning, financing and executing projects of housing and office building construction for Police and other organizations under Home Department of Government of Maharashtra. As the Director General of Anti-Corruption Bureau, he initiated a policy document on Vigilance matters for Government of Maharashtra and took many steps for checking corruption in Government working. He was responsible for all operational matters in the elite Special Protection Group, charged with the responsibility of the proximate security of the Prime Minister and former Prime Ministers. He has knowledge and experience of security and Intelligence matters at the state and national level.

D. Sundaram

Mr. D. Sundaram is Non-Executive Independent Director of GlaxoSmithKline Pharmaceuticals Ltd., since July 27, 2009. He is a commerce graduate and a post graduate in Management Studies from Madras University. He is a Fellow of the Institute of Cost Accountants and has done the Advanced Management Programme at Harvard Business School. Mr. Sundaram joined Hindustan Lever (Unilever group) in India as Management Trainee in 1975 and held increasingly senior roles in HLL in Accounting, Commercial and Treasury functions at Mumbai, was Finance Officer at Unilever (London) for Africa and Middle East Region, Finance Director and Board Member of Brooke Bond Lipton India Limited and was Senior Vice-President (Finance and IT), South Asia and Middle East Group based at London. Mr. Sundaram was appointed as Finance Director and Board Member of Hindustan Lever Limited and subsequently became Vice-Chairman and CFO of the Company; he was also responsible for Pakistan, Bangladesh and Sri Lanka. Mr. Sundaram was twice awarded CFO of the year for the FMCG sector by CNBC TV 18 in 2006 and 2009; he was given the “icon of the profession’’ award by Institute of Cost Accountants. Currently he is the Vice-Chairman and Managing Director of TVS Capital Funds Limited since July 2009. He is an Independent Director on the Boards of State Bank of India, SBI Capital Market and TVS Electronics Ltd among others. He is the Chairman of the Audit Committee of SBI Capital Market and TVS Electronics Limited. He is a Member of Audit Committee and Remuneration Committee of State Bank of India.
Search Stocks